Elmwood Wealth Management’s GSK GSK Stock Holding History

Elmwood Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-680	Closed	-$37K	–	190
2021 Q4	$37K	Buy	+680	New	+$35.4K	0.02%	207
2020 Q3	$6K	Hold	110	–	–	﹤0.01%	206
2020 Q2	$6K	Hold	110	–	–	﹤0.01%	206
2020 Q1	$5.39K	Buy	+110	New	+$5.87K	0.01%	223
2019 Q4	–	Sell	-110	Closed	-$6K	–	149
2019 Q3	$6K	Hold	110	–	–	0.01%	199
2019 Q2	$6K	Hold	110	–	–	0.01%	218
2019 Q1	$6K	Hold	110	–	–	0.01%	208
2018 Q4	$5K	Hold	110	–	–	﹤0.01%	223
2018 Q3	$5.54K	Hold	110	–	–	﹤0.01%	227
2018 Q2	$5.56K	Hold	110	–	–	0.01%	220
2018 Q1	$5.39K	Buy	+110	New	+$5.12K	0.01%	223

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Elmwood Wealth Management's GSK Position: Q1 2022 in Review

Elmwood Wealth Management sold out of GSK (GSK) in Q1 2022, closing a stake of 680 shares — an estimated $37K sold.

Elmwood Wealth Management first reported a position in GSK in Q1 2018 and held it in 11 quarters. The position peaked at $37K in Q4 2021. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

Elmwood Wealth Management reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
Elmwood Wealth Management sold 680 GSK shares in Q1 2022, an estimated $37K.
Elmwood Wealth Management first reported a position in GSK in Q1 2018 and held it in 11 quarters.
Elmwood Wealth Management's GSK position peaked at $37K in Q4 2021.
929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.